agilon health, inc. (NYSE:AGL - Get Free Report) saw unusually large options trading on Friday. Stock investors bought 6,103 call options on the stock. This is an increase of 471% compared to the average volume of 1,069 call options.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on AGL shares. Sanford C. Bernstein increased their price objective on agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a research report on Wednesday, January 15th. Needham & Company LLC reissued a "hold" rating on shares of agilon health in a report on Friday. Royal Bank of Canada boosted their price objective on shares of agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a report on Wednesday, February 26th. Citigroup raised shares of agilon health from a "sell" rating to a "neutral" rating and upped their price objective for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Finally, Macquarie started coverage on agilon health in a research report on Monday, December 16th. They set a "neutral" rating and a $3.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $3.95.
Read Our Latest Analysis on agilon health
Institutional Investors Weigh In On agilon health
Large investors have recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC bought a new position in agilon health during the 4th quarter valued at about $155,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of agilon health by 24.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company's stock valued at $1,516,000 after acquiring an additional 157,610 shares during the last quarter. Two Sigma Advisers LP raised its stake in shares of agilon health by 4,393.5% in the fourth quarter. Two Sigma Advisers LP now owns 480,800 shares of the company's stock valued at $914,000 after acquiring an additional 470,100 shares during the last quarter. Two Sigma Investments LP boosted its holdings in shares of agilon health by 73.7% in the 4th quarter. Two Sigma Investments LP now owns 857,867 shares of the company's stock worth $1,630,000 after acquiring an additional 363,855 shares in the last quarter. Finally, State of Wyoming grew its position in agilon health by 89.3% during the 4th quarter. State of Wyoming now owns 122,504 shares of the company's stock worth $233,000 after acquiring an additional 57,802 shares during the last quarter.
agilon health Price Performance
NYSE:AGL traded down $0.01 during trading hours on Tuesday, reaching $4.47. The company had a trading volume of 3,681,686 shares, compared to its average volume of 4,620,713. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a 50-day moving average of $3.58 and a two-hundred day moving average of $2.95. agilon health has a one year low of $1.50 and a one year high of $7.73. The firm has a market capitalization of $1.84 billion, a PE ratio of -4.76 and a beta of 0.67.
agilon health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.